Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Pharmadrug Inc C.PHRX

Alternate Symbol(s):  LMLLF

PharmaDrug Inc. is a Canada-based specialty pharmaceutical company. The Company is focused on the research, development and commercialization of controlled-substances and natural medicines, such as psychedelics and previously approved drugs. The Company’s subsidiary, Sairiyo Therapeutics (Sairiyo), is a biotech company that specializes in researching and reformulating established natural medicines. Sairiyo is engaged in the development of its patented reformulation of cepharanthine, a drug that has shown substantial third party validated potential for the treatment of infectious diseases and rare cancers. Sairiyo is also conducting research and development (R&D) in the psychedelics space for the treatment of non-neuropsychiatric conditions. The Company also operates through SecureDose Synthetics Inc., which is a pharmaceutical research and development company focused on the development of synthetic formulations of existing drugs for potential commercialization and distribution.


CSE:PHRX - Post by User

Post by Acura001on Dec 23, 2020 8:52am
92 Views
Post# 32167894

TRIP News.

TRIP News.

Toronto, Ontario--(Newsfile Corp. - December 23, 2020) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC: TRUFF) ("Red Light Holland" or the "Company") is pleased to announce that it has hired Wellington-Dupont Public Affairs ("Wellington-Dupont") to provide government relations support and lobbying services on behalf of the Company. Wellington-Dupont has approached the Government of Canada in the hopes of initiating first steps for Red Light Holland to receive an exemption for controlled substances use as part of clinical studies, in order to safely analyze the potential positive impacts of psilocybin on mental health.

"We have a big idea. But we need to carefully proceed, in order for it to hopefully come to fruition," said Red Light Holland CEO and director Todd Shapiro. "This is why we have hired expert lobbying and government relations firm, Wellington Dupont Public Affairs. Through Wellington Dupont, we look forward to engaging the federal government to discuss the usage of natural psilocybin products, and their potential benefits."

"We are pleased to represent Red Light Holland as they seek an exemption for controlled substances use as part of a clinical study," said Summer Senter, Consultant Lobbyist at Wellington-Dupont Public Affairs. "Together we are working with another group to build a detailed plan that will lead to potentially ground-breaking and positive change in Canada. We look forward to sharing more news, when appropriate."

<< Previous
Bullboard Posts
Next >>